WINTON GROUP Ltd Raises Position in USANA Health Sciences, Inc. (NYSE:USNA)
WINTON GROUP Ltd lifted its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 41.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,505 shares of the company’s stock after buying an additional 3,077 shares during the period. WINTON GROUP Ltd’s holdings in USANA Health Sciences were worth $834,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Royce & Associates LP boosted its position in shares of USANA Health Sciences by 66.4% in the first quarter. Royce & Associates LP now owns 381 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the period. Great West Life Assurance Co. Can boosted its holdings in USANA Health Sciences by 43.8% in the fourth quarter. Great West Life Assurance Co. Can now owns 1,516 shares of the company’s stock valued at $172,000 after purchasing an additional 462 shares during the last quarter. SG Americas Securities LLC purchased a new position in USANA Health Sciences in the first quarter valued at about $193,000. Symons Capital Management Inc. purchased a new position in USANA Health Sciences in the first quarter valued at about $202,000. Finally, Campbell & CO Investment Adviser LLC purchased a new position in USANA Health Sciences in the first quarter valued at about $211,000. 59.13% of the stock is owned by institutional investors.
A number of research analysts recently commented on the company. ValuEngine raised Westpac Banking from a “sell” rating to a “hold” rating in a report on Wednesday, May 22nd. Tigress Financial assumed coverage on USANA Health Sciences in a report on Tuesday, April 16th. They issued a “buy” rating for the company. TheStreet raised VEON from a “d+” rating to a “c-” rating in a report on Thursday, July 11th. Pivotal Research reissued a “hold” rating and issued a $25.00 price target (up previously from $23.00) on shares of Under Armour in a report on Wednesday, July 24th. Finally, Sidoti downgraded OMNOVA Solutions from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a report on Wednesday, July 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $72.50.
USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $0.91 EPS for the quarter, missing analysts’ consensus estimates of $0.93 by ($0.02). The business had revenue of $256.00 million during the quarter, compared to analysts’ expectations of $254.66 million. USANA Health Sciences had a net margin of 9.68% and a return on equity of 26.85%. The company’s revenue for the quarter was down 15.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.36 EPS. On average, sell-side analysts predict that USANA Health Sciences, Inc. will post 3.9 EPS for the current year.
USANA Health Sciences Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Read More: What is a Buy-Side Analyst?
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.